Position in ILMN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$62,167,783
+$42,955,729 QoQ
Shares Held
504,363
+244.3% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Derivatives in ILMN
reported options exposure · as of Mar 31, 2026CallValue
$12,326
CallShares
100
PutValue
$49,304
PutShares
400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $531,017,373 across 25 Diagnostics & Research names. ILMN ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
477,250 | $234,582,691 | |
| 2 | WAT |
Waters Corp /De/
|
226,886 | $67,566,650 | |
| 3 | ILMN |
Illumina, Inc.
This page
|
504,363 | $62,167,783 | |
| 4 | DGX |
Quest Diagnostics Inc
|
200,278 | $39,250,481 | |
| 5 | QGEN |
Qiagen N.V.
|
789,998 | $31,631,519 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
49,295 | $27,698,367 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
149,651 | $25,814,797 | |
| 8 | NTRA |
Natera, Inc.
|
53,702 | $10,739,862 |
All Filings in ILMN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,167,783 | 504,363 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $49,304 | 400 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $12,326 | 100 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $19,212,054 | 146,478 | Shares | Other | 2026-02-13 | |
| 2025-12-31 | $131,160 | 1,000 | Call | Other | 2026-02-13 | |
| 2025-12-31 | $13,116 | 100 | Put | Other | 2026-02-13 | |
| 2025-06-30 | $5,690,729 | 59,645 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $3,175,742 | 40,027 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $161,677,492 | 1,239,763 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $77,627,719 | 743,703 | Shares | Other | 2024-08-14 | |
| 2023-12-31 | $20,049,345 | 148,023 | Shares | Other | 2024-02-14 | |
| 2022-12-31 | $8,544,129 | 43,439 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $9,718,041 | 52,362 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $118,136,546 | 658,735 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $17,368,374 | 51,101 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $67,964,417 | 183,649 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $54,253,105 | 137,502 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $15,060,530 | 40,312 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $31,677,695 | 105,360 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||